- Home
- AKRO vs COLD Comparison
AKRO vs COLD Comparison
Compare AKRO & COLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AKRO
- COLD
- Stock Information
- Founded
- AKRO 2017
- COLD 1903
- Country
- AKRO United States
- COLD United States
- Employees
- AKRO N/A
- COLD N/A
- Industry
- AKRO Biotechnology: Pharmaceutical Preparations
- COLD Real Estate Investment Trusts
- Sector
- AKRO Health Care
- COLD Real Estate
- Exchange
- AKRO Nasdaq
- COLD Nasdaq
- Market Cap
- AKRO 3.7B
- COLD 3.9B
- IPO Year
- AKRO 2019
- COLD 2018
- Fundamental
- Price
- AKRO $54.04
- COLD $11.75
- Analyst Decision
- AKRO Buy
- COLD Hold
- Analyst Count
- AKRO 10
- COLD 15
- Target Price
- AKRO $73.56
- COLD $18.40
- AVG Volume (30 Days)
- AKRO 2.1M
- COLD 5.9M
- Earning Date
- AKRO 11-07-2025
- COLD 11-06-2025
- Dividend Yield
- AKRO N/A
- COLD 7.83%
- EPS Growth
- AKRO N/A
- COLD N/A
- EPS
- AKRO N/A
- COLD N/A
- Revenue
- AKRO N/A
- COLD $2,607,407,000.00
- Revenue This Year
- AKRO N/A
- COLD N/A
- Revenue Next Year
- AKRO N/A
- COLD $2.11
- P/E Ratio
- AKRO N/A
- COLD N/A
- Revenue Growth
- AKRO N/A
- COLD N/A
- 52 Week Low
- AKRO $21.34
- COLD $11.46
- 52 Week High
- AKRO $58.40
- COLD $24.74
- Technical
- Relative Strength Index (RSI)
- AKRO 67.29
- COLD 31.82
- Support Level
- AKRO $53.90
- COLD $12.35
- Resistance Level
- AKRO $54.31
- COLD $12.80
- Average True Range (ATR)
- AKRO 0.23
- COLD 0.51
- MACD
- AKRO -0.25
- COLD -0.16
- Stochastic Oscillator
- AKRO 66.30
- COLD 9.97
About AKRO Akero Therapeutics Inc.
Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical needs. Its focus is nonalcoholic steatohepatitis (MASH), or NASH, a disease without any approved therapies. The company's product candidate efruxifermin is an FGF21 analog with properties that have the potential to address the core processes underlying NASH pathogenesis.
About COLD Americold Realty Trust Inc.
Americold Realty Trust Inc is the world's second-largest owner and operator of temperature-controlled warehouses behind privately held Lineage Logistics. The Atlanta, Georgia-based firm owns and operates approximately 239 temperature-controlled warehouses, spanning 1.4 billion cubic feet. In 2022, the firm derived more than 80% of its revenue from the United States but also has sizable operations in Europe, Canada, Australia, and New Zealand. Americold supplements its core business by providing supply management and transportation services to its various customers. It operates as a real estate investment trust.